Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP.

J Pharmacol Exp Ther. 2003 Mar;304(3):1093-102.

2.

Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice.

Przetak M, Chow J, Cheng H, Rose J, Hawkins LD, Ishizaka ST.

Vaccine. 2003 Feb 14;21(9-10):961-70.

PMID:
12547609
3.

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.

Hawkins LD, Ishizaka ST, McGuinness P, Zhang H, Gavin W, DeCosta B, Meng Z, Yang H, Mullarkey M, Young DW, Yang H, Rossignol DP, Nault A, Rose J, Przetak M, Chow JC, Gusovsky F.

J Pharmacol Exp Ther. 2002 Feb;300(2):655-61.

4.

Cloning of cDNA for human granzyme 3.

Przetak MM, Yoast S, Schmidt BF.

FEBS Lett. 1995 May 15;364(3):268-71.

5.

Commercial levels of chymosin production by Aspergillus.

Dunn-Coleman NS, Bloebaum P, Berka RM, Bodie E, Robinson N, Armstrong G, Ward M, Przetak M, Carter GL, LaCost R, et al.

Biotechnology (N Y). 1991 Oct;9(10):976-81.

PMID:
1368725

Supplemental Content

Loading ...
Support Center